Literature DB >> 27514999

Long-term culture of human odontoma-derived cells with a Rho kinase inhibitor.

Katsuhiro Uzawa1, Atsushi Kasamatsu2, Tomoaki Saito3, Toshikazu Takahara3, Yasuyuki Minakawa3, Kazuyuki Koike2, Masanobu Yamatoji2, Dai Nakashima2, Morihiro Higo2, Yosuke Sakamoto2, Masashi Shiiba4, Hideki Tanzawa5.   

Abstract

Because of cellular senescence/apoptosis, no effective culture systems are available to maintain replication of cells from odontogenic tumors especially for odontoma, and, thus, the ability to isolate human odontoma-derived cells (hODCs) for functional studies is needed. The current study was undertaken to develop an approach to isolate hODCs and fully characterize the cells in vitro. The hODCs were cultured successfully with a Rho-associated protein kinase inhibitor (Y-27632) for an extended period with stabilized lengths of the telomeres to sustain a similar phenotype/property as the primary tumoral cells. While the hODCs showed stable long-term expansion with expression of major dental epithelial markers including dentin sialophosphoprotein (DSPP) even in the three-dimensional microenvironment, they lack the specific markers for the characteristics of stem cells. Moreover, cells from dental pulp showed significant up-regulation of DSPP when co-cultured with the hODCs, while control fibroblasts with the hODCs did not. Taken together, we propose that the hODCs can be isolated and expanded over the long term with Y-27632 to investigate not only the development of the hODCs but also other types of benign human tumors.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dentin sialophosphoprotein; Long-term culture; Mineralization; Odontoma; Rho kinase inhibitor; Telomere

Mesh:

Substances:

Year:  2016        PMID: 27514999     DOI: 10.1016/j.yexcr.2016.08.005

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

1.  Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.

Authors:  Nao Koide; Atsushi Kasamatsu; Yosuke Endo-Sakamoto; Sho Ishida; Toshihiro Shimizu; Yasushi Kimura; Isao Miyamoto; Shusaku Yoshimura; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

2.  SYT12 plays a critical role in oral cancer and may be a novel therapeutic target.

Authors:  Keitaro Eizuka; Dai Nakashima; Noritoshi Oka; Sho Wagai; Toshikazu Takahara; Tomoaki Saito; Kazuyuki Koike; Atsushi Kasamatsu; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  J Cancer       Date:  2019-08-27       Impact factor: 4.207

3.  Aberrant GIMAP2 expression affects oral squamous cell carcinoma progression by promoting cell cycle and inhibiting apoptosis.

Authors:  Mari Komatsu; Kengo Saito; Isao Miyamoto; Kazuyuki Koike; Manabu Iyoda; Dai Nakashima; Atsushi Kasamatsu; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  Oncol Lett       Date:  2021-12-14       Impact factor: 2.967

4.  Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer.

Authors:  Reo Fukushima; Atsushi Kasamatsu; Dai Nakashima; Morihiro Higo; Kazuaki Fushimi; Hiroki Kasama; Yosuke Endo-Sakamoto; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  J Cancer       Date:  2018-09-07       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.